Byetta is the brand name for the chemical exenatide, an injectable incretin mimetic-class drug prescribed to help those dealing with type-2 diabetes control their blood sugar levels.
Byetta was developed by Amylin Pharmaceuticals and approved by the FDA in 2005. Bristol-Myers Squibb (BMS) then acquired Amylin in 2012, and with it, the rights to manufacture Byetta. In just the last quarter of 2012 after purchasing Amylin, BMS earned $149 million from Byetta.
Byetta is injected in the arm, thigh or abdomen twice each day before meals. A similar once-weekly version called Bydureon is also available. Both drugs work by increasing the hormone GLP-1, which helps the body make more insulin. They also slow the digestive rate to limit the amount of glucose entering the blood.
Unfortunately, diabetes drugs like Byetta have been linked to increased risks of pancreatitis, pancreatic cancer and thyroid cancer. While the FDA forced Amylin to add warnings for pancreatitis, neither they nor BMS have warned patients of the more severe risks for pancreatic cancer and thyroid cancer.
Lawyers are currently helping those affected by cancer after using Byetta file claims against BMS. They can let you know what help is available and how long you have to take action.
If you or a loved one have been diagnosed with pancreatic cancer or thyroid cancer after using Byetta, it is important to speak with a lawyer. You may be entitled to substantial compensation. Contact us today.
The FDA first warned of Byetta risks in 2007 after receiving a high number of reports of patients suffering pancreatitis, including 6 deaths from the disease. The agency added additional pancreatic warnings in 2008 and a warning for kidney failure risks in 2009.
Amid reports of Byetta thyroid cancer in 2010, the FDA recommended that Amylin Pharmaceuticals and Eli Lilly, the companies manufacturing and selling the drug at the time, conduct additional studies to determine if there is a connection between Byetta and thyroid cancer.
In 2011, researchers from UCLA conducted their own study into Byetta, which suggested the medication could increase the risk of thyroid cancer by 473% and the risk of pancreatic cancer by 290%. However, they cautioned that further testing was necessary.
Most recently, the Journal for the American Medical Association published a study in February of 2013 indicating diabetes drugs like Byetta could double the risk of pancreatitis, which can lead to pancreatic cancer. The FDA followed with a new warning in March of 2013.
If you or a family member have been diagnosed with pancreatic cancer or thyroid cancer after using Byetta, it is important to speak with a lawyer as soon as possible. You may be entitled to recover from the maker of the drug for your damages. However, time is limited.
Since lawsuits for defective drug injuries can be very complex, it is important to choose a lawyer with experience in this type of case. DrugRisk only recommends lawyers and law firms that have already handled Byetta lawsuits.
Contact us today for more information on the warnings, research, side effects and legal news related to Byetta and other diabetes drugs, or to speak with a lawyer. We are available 24 hours a day to help.